Control & Destroy Superbugs
Mitigate anti-biotic resistant pathogens like
MRSA, VRE, CRE and others
MRSA, VRE, CRE and others
Control & Destroy Superbugs
Mitigate anti-biotic resistant pathogens like MRSA, VRE, CRE and others
UVMED devices address the need to find viable alternatives for control of Superbugs! The prevalence of infectious diseases caused by multidrug-resistant microorganisms is relentlessly increasing worldwide owing to the excessive use of antibiotics. Antibiotic resistance has led to a major research effort to find alternative anti-microbial approaches (chemical-free) to which, it is hypothesized, microorganisms will not be easily able to develop resistance. The light-induced damage to the DNA and RNA of a microorganism often results from the dimerization of pyrimidine molecules. In particular, thymine (which is only found only in DNA) produces cyclobutane dimers. When thymine molecules are dimerized, it becomes very difficult for the nucleic acids to replicate and if replication does occur it often produces a defect that prevents the microorganism from being viable. (Expert Rev Anti Infect Ther. 2012 Feb; 10(2): 185–195.).
UVMED devices address the need to find viable alternatives for control of Superbugs! The prevalence of infectious diseases caused by multidrug-resistant microorganisms is relentlessly increasing worldwide owing to the excessive use of antibiotics. Antibiotic resistance has led to a major research effort to find alternative anti-microbial approaches (chemical-free) to which, it is hypothesized, microorganisms will not be easily able to develop resistance. The light-induced damage to the DNA and RNA of a microorganism often results from the dimerization of pyrimidine molecules. In particular, thymine (which is only found only in DNA) produces cyclobutane dimers. When thymine molecules are dimerized, it becomes very difficult for the nucleic acids to replicate and if replication does occur it often produces a defect that prevents the microorganism from being viable. (Expert Rev Anti Infect Ther. 2012 Feb; 10(2): 185–195.).